PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients

Elizabeth A Punnoose; Roberta Ferraldeschi; Edith Szafer-Glusman; Eric K Tucker; Sankar Mohan; Penelope Flohr; Ruth Riisnaes; Susana Miranda; Ines Figueiredo; Daniel Nava Rodrigues; Aurelius Omlin; Carmel Pezaro; Jin Zhu; Lukas Amler; Premal Patel; Yibing Yan; Natalee Bales; Shannon L Werner; Jessica Louw; Ajay Pandita; Dena Marrinucci; Gerhardt Attard; Johann de Bono

doi:10.1038/bjc.2015.332

PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients

British Journal of Cancer ◽

10.1038/bjc.2015.332 ◽

2015 ◽

Vol 113 (8) ◽

pp. 1225-1233 ◽

Cited By ~ 56

Author(s):

Elizabeth A Punnoose ◽

Roberta Ferraldeschi ◽

Edith Szafer-Glusman ◽

Eric K Tucker ◽

Sankar Mohan ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumour Cells ◽

Tumour Tissue ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Pten Loss ◽

Castration Resistant

Download Full-text

Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents

British Journal of Cancer ◽

10.1038/bjc.2015.63 ◽

2015 ◽

Vol 112 (7) ◽

pp. 1166-1174 ◽

Cited By ~ 52

Author(s):

M Crespo ◽

G van Dalum ◽

R Ferraldeschi ◽

Z Zafeiriou ◽

S Sideris ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumour Cells ◽

Receptor Expression ◽

Androgen Receptor Expression ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer

European Journal of Cancer ◽

10.1016/j.ejca.2019.08.005 ◽

2019 ◽

Vol 121 ◽

pp. 48-54 ◽

Cited By ~ 3

Author(s):

Bodine P.S. Belderbos ◽

Anieta M. Sieuwerts ◽

Esther Oomen-de Hoop ◽

Bianca Mostert ◽

Jaco Kraan ◽

...

Keyword(s):

Prostate Cancer ◽

Cell Count ◽

Tumour Cell ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Circulating Tumour Cell

Download Full-text

P055 Changes in prostate-specific antigen levels are not associated with changes in circulating tumour cells levels during chemotherapy in castration-resistant prostate cancer

European Urology Supplements ◽

10.1016/s1569-9056(14)61278-1 ◽

2014 ◽

Vol 13 (5) ◽

pp. 129

Author(s):

O. Čapoun ◽

M. Jančíková ◽

V. Mikulová ◽

H. Honová ◽

K. Kološtová ◽

...

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1–3

European Urology ◽

10.1016/j.eururo.2016.09.021 ◽

2017 ◽

Vol 71 (4) ◽

pp. e105-e106 ◽

Cited By ~ 1

Author(s):

Marcus V. Cronauer ◽

Axel S. Merseburger ◽

M. Raschid Hoda

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Next Generation ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Circulating tumour cells (CTC) count and prostate-specific antigen (PSA) response measures in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with docetaxel (Doc)

Annals of Oncology ◽

10.1093/annonc/mdz248.046 ◽

2019 ◽

Vol 30 ◽

pp. v350

Author(s):

R Lozano Mejorada ◽

D. Lorente ◽

E. Castro ◽

D. Bianchini ◽

P. Nombela ◽

...

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Psa Response ◽

Response Measures

Download Full-text

701 IMMUNOMAGNETIC QUANTIFICATION OF CIRCULATING TUMOUR CELLS (CTCS) AS NEW PROGNOSTIC AND PREDICTIVE FACTOR IN CASTRATION RESISTANT PROSTATE CANCER (CRPC): PRELIMINARY RESULTS

European Urology Supplements ◽

10.1016/s1569-9056(09)60695-3 ◽

2009 ◽

Vol 8 (4) ◽

pp. 296

Author(s):

Rocca M. Cossu ◽

E. Verri ◽

M.T. Sandri ◽

C. Marenghi ◽

E. Botteri ◽

...

Keyword(s):

Prostate Cancer ◽

Predictive Factor ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Preliminary Results ◽

Castration Resistant

Download Full-text

Circulating tumour cells in patients with metastatic castration resistant prostate cancer under treatment with cabazitaxel - a prospective biomarker study from the Hellenic Oncology Research Group

European Urology Supplements ◽

10.1016/s1569-9056(19)30871-1 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1213-e1214

Author(s):

Z. Zafeiriou ◽

N. Kostakopoulos ◽

Z. Messaritakis ◽

E. Bournakis ◽

A. Kotsakis ◽

...

Keyword(s):

Prostate Cancer ◽

Research Group ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Oncology Research

Download Full-text

675P HER2 expression in circulating tumour cells is associated with poor outcomes in patients with metastatic castration resistant prostate cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.08.934 ◽

2020 ◽

Vol 31 ◽

pp. S540

Author(s):

D. Maillet ◽

N. Allioli ◽

J. Peron ◽

A. Plesa ◽

M. Decaussin ◽

...

Keyword(s):

Prostate Cancer ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Her2 Expression ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Poor Outcomes

Download Full-text

C163 Prostate-specific antigen level and detection of circulating tumour cells in castration-resistant prostate cancer

European Urology Supplements ◽

10.1016/s1569-9056(13)62011-4 ◽

2013 ◽

Vol 12 (4) ◽

pp. e1271, C163

Author(s):

O. Čapoun ◽

V. Mikulová ◽

M. Jančíková ◽

H. Honová ◽

K. Kološtová ◽

...

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Tumour Cells ◽

Prostate Specific Antigen Level ◽

Circulating Tumour Cells ◽

Antigen Level ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Reply to Marcus V. Cronauer, Axel S. Merseburger, and M. Raschid Hoda's Letter to the Editor re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1–3

European Urology ◽

10.1016/j.eururo.2016.09.022 ◽

2017 ◽

Vol 71 (4) ◽

pp. e107-e108 ◽

Cited By ~ 1

Author(s):

Julie Steinestel ◽

Christof Bernemann ◽

Andres J. Schrader ◽

Jochen K. Lennerz

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Next Generation ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Letter To The Editor

Download Full-text